Welcome to the Team page of Drug Discovery Alliances, where innovation converges with expertise. Our journey towards groundbreaking pharmaceutical solutions is fueled by the collective brilliance of our diverse and dedicated team members. Each individual brings unique insights, skills, and perspectives, contributing to a collaborative environment that thrives on pushing boundaries and redefining possibilities. Get to know the faces driving our mission forward and shaping the future of drug discovery.

Meet the Brilliant Minds Behind Drug Discovery Alliances

Deborah Minor, Ph.D., CEO

Deborah has decades of business development experience marketing contract services, drug licensing and new technologies to the pharmaceutical industry. She founded Drug Discovery Alliances, Inc. in 2001 to connect pharmaceutical and biotech companies with top industry contractors who facilitate and speed projects. Deborah earned a Ph.D. in Medicinal Chemistry from University of North Carolina, Chapel Hill and has worked as an organic chemist for Rhone Poulenc. She subsequently worked for Accelyrs and MDL, marketing molecular modeling technologies and databases including Beilstein and Crossfire to the pharmaceutical industry.

Our Team

DDA’s team of 10 consultants has a unique combination of expertise, industry insight and empathy, buttressed by DDA’s tremendous network of resources. Chosen for their expertise and matched to project needs, team members act as trusted guides, helping clients navigate the treacherous and challenging journey from discovery to commercialization while expertly sidestepping the many pitfalls and dead ends that can derail projects.

The team is comprised of a global portfolio of world-class CROs, CMOs, consultants and other partners who focus on reducing risk, solving problems and seeing projects through to successful completion.

Deborah Minor